LEADER 01011nlm0 22003251i 450 001 990009815750403321 005 20140128123623.0 010 $a9780470085004$bonline 035 $a000981575 035 $aFED01000981575 035 $a(Aleph)000981575FED01 035 $a000981575 100 $a20140128d2007----km-y0itay0103----ba 101 0 $aeng 135 $adrnn-008mamaa 200 1 $aDiffraction, fourier optics, and imaging$bRisorsa elettronica$fOkan K. Ersoy 210 $aHoboken, N. J.$cWiley-Interscience$d2007 230 $aDocumento elettronico 336 $aTesto 337 $aFormato pdf 676 $a535.42 700 1$aErsoy,$bOkan K.$0521963 801 0$aIT$bUNINA$gREICAT$2UNIMARC 856 4 $zFull text per gli utenti Federico II$uhttp://onlinelibrary.wiley.com/book/10.1002/0470085002 901 $aEB 912 $a990009815750403321 961 $aDiffraction 961 $aFourier transform optics 996 $aDiffraction, fourier optics, and imaging$9835215 997 $aUNINA LEADER 05491nam 2200745Ia 450 001 9910811199603321 005 20200520144314.0 010 $a9786613333230 010 $a9781283333238 010 $a1283333236 010 $a9781119972709 010 $a1119972701 010 $a9781119998938 010 $a111999893X 010 $a9781119998464 010 $a1119998468 035 $a(CKB)2550000000063588 035 $a(EBL)697586 035 $a(OCoLC)773799268 035 $a(SSID)ssj0000539474 035 $a(PQKBManifestationID)11357046 035 $a(PQKBTitleCode)TC0000539474 035 $a(PQKBWorkID)10568342 035 $a(PQKB)11406157 035 $a(OCoLC)768230372 035 $a(MiAaPQ)EBC697586 035 $a(Perlego)1010859 035 $a(EXLCZ)992550000000063588 100 $a20110518d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aNeuroimaging in addiction /$fBryon Adinoff and Elliot Stein 205 $a1st ed. 210 $aChichester, West Sussex $cJohn Wiley & Sons$d2011 215 $a1 online resource (373 p.) 300 $aDescription based upon print version of record. 311 08$a9780470660140 311 08$a0470660147 320 $aIncludes bibliographical references and index. 327 $aNeuroimagingin Addiction; Contents; Foreword; List of Contributors; 1 Introduction; 2 An Integrated Framework for Human Neuroimaging Studies of Addiction from a Preclinical Perspective; 2.1 Introduction; 2.2 A Conceptual Framework for Understanding Drug Addiction Based on Preclinical Observations; 2.3 Neuropharmacological Considerations; 2.4 Neuropathology of Chronic Drug Abuse; 2.5 Impulsivity: An Endophenotype for Drug Addiction; 2.6 Compulsivity: Craving versus Drug-Seeking; 2.7 Summary; References 327 $a3 Structural and Functional Neuroimaging Methods: Applications to Substance Abuse and Addiction3.1 Introduction; 3.2 MRI Based Imaging Tools and their Application to Drug Abuse Research; 3.3 Molecular Imaging with PET and SPECT; 3.4 Summary and Peek into the Future; References; 4 Functional Neuroimaging of the Acute Effects of Drugs of Abuse; 4.1 Introduction; 4.2 Fundamental Neuronal Systems Related to Abuse Liability in Humans; 4.3 Psychostimulants; 4.4 Alcohol; 4.5 Cannabis and the Cannabinoids; 4.6 Opioids; 4.7 Conclusions and Future Directions; References; 5 Reward Processing 327 $a5.1 Introduction5.2 Neurotransmitter Systems Implicated in Reward Processing; 5.3 Neurotransmitter Systems Involved in Drug-Related Reward Processing; 5.4 Alterations in the Mesostriatal System in Addiction; 5.5 Summary and Outlook; 5.6 Acknowledgments; References; 6 A Neuroimaging Approach to the Study of Craving; 6.1 A Neuroimaging Approach to the Study of Craving; 6.2 Neural Response During Cue-Elicited Craving; 6.3 Associations between Neural and Subjective Response During Cue-Elicited Craving; 6.4 Modulators of Neural Response During Cue-Elicited Craving 327 $a6.5 Effects of Intervention on the Neural Response During Cue-Elicited Craving6.6 Summary and Integration of Findings; 6.7 Conclusions; References; 7 Impulsivity and Addiction; 7.1 Introduction; 7.2 Impulsivity as Reward versus Control; 7.3 The Neurobiology of Impulsivity; 7.4 Impulsivity and Risk for Developing a Drug Use Disorder; 7.5 Impulsivity in Current Users; 7.6 Impulsivity, Abstinence, and Relapse; 7.7 Conclusion; References; 8 Cognitive Disruptions in Drug Addiction: a Focus on the Prefrontal Cortex; 8.1 Introduction; 8.2 Attention; 8.3 Working Memory; 8.4 Decision-Making 327 $a8.5 Pre-Morbid Vulnerabilities8.6 Other Brain Regions; 8.7 Limitations Across All Studies; 8.8 Treatment Implications; 8.9 General Summary and Conclusions; 8.10 Acknowledgments; References; 9 Neural Mechanisms of Stress and Addiction; 9.1 Stress and Addiction; 9.2 Neural Circuits of Stress Regulation; 9.3 Dysfunction in the Neural Circuits Underlying Stress and Addiction; 9.4 Interplay of Gene, Stress, and Drug Intake; 9.5 Acknowledgments; References; 10 Anatomical and Neurochemical Evidence of Neurotoxic Changes in Psychostimulant Abuse and Dependence; 10.1 Introduction 327 $a10.2 Characteristics of Psychostimulants 330 $aNeuroimaging in Addiction presents an up-to-date, comprehensive review of the functional and structural imaging human studies that have greatly advanced our understanding of this complex disorder. Approaching addiction from a conceptual rather than a substance-specific perspective, this book integrates broad neuropsychological constructs that consider addiction as a neuroplastic process with genetic, developmental, and substance-induced contributions. The internationally recognized contributors to this volume are leaders in clinical imaging with expertise that spans the addiction spec 606 $aBrain$xEffect of drugs on 606 $aBrain$xRadiography 606 $aCompulsive behavior$xMagnetic resonance imaging 615 0$aBrain$xEffect of drugs on. 615 0$aBrain$xRadiography. 615 0$aCompulsive behavior$xMagnetic resonance imaging. 676 $a616.8/047572 700 $aAdinoff$b Bryon$01670494 701 $aStein$b Elliot$01670495 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910811199603321 996 $aNeuroimaging in addiction$94032387 997 $aUNINA